Therapy News and Research

RSS

Cannabis products associated with sustained improvements in patients with inflammatory arthritis

The sustained use of medical cannabis preparations provides safe and effective relief for patients with inflammatory arthritis, according to observational data published in the journal Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders.

6 Oct 2026

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies worldwide, has entered a research collaboration with TrAMPoline Pharma and Eduardo Davila, PhD, at the University of Colorado to develop an automated manufacturing approach for tumor-infiltrating lymphocyte (TIL) therapies targeting solid tumors.

6 Oct 2026

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

Alliance Foundation Trials, LLC (AFT), a national leader in conducting innovative, practice-changing cancer clinical trials, and Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the launch of AFT-70 NAVIGATE, a randomized phase III trial evaluating a novel molecular residual disease (MRD)-guided treatment strategy for patients with intermediate and high-risk ER-positive/HER2-negative early breast cancer.

5 Oct 2026

New BCR analysis method tracks immune recovery after stem cell transplantation

A research team led by Associate Professor Yohei Funakoshi, Associate Professor Kimikazu Yakushijin, and Professor Hironobu Minami of the Division of Medical Oncology/Hematology at Kobe University Hospital, together with Associate Professor Goh Ohji of the Division of Infectious Disease Therapeutics and Takaji Matsutani of Anymics Inc., has developed the pGen-SHM plot.

5 Oct 2026

New model predicts growth hormone therapy response in children with short stature

Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for their age and sex without any identifiable medical cause.

5 Oct 2026

New workflow rapidly identifies deadly fungal bloodstream infections

Bloodstream infections are a persistent threat to hospitalized patients, and those caused by fungi are particularly dangerous. Candida species are responsible for most invasive fungal infections worldwide and rank among the leading causes of hospital-acquired bloodstream infections overall.

5 Oct 2026

Enlicitide offers oral treatment option for patients avoiding cholesterol injections

In 2015, a new class of cholesterol-lowering injectable drugs called PCSK9-inhibitors was approved by the Food and Drug Administration (FDA) as a result of clinical research led by UT Southwestern.

5 Oct 2026

Tailored treatments allow less invasive surgery for breast cancer patients

For many patients diagnosed with breast cancer, the first instinct may be to pursue the most aggressive treatment possible.

5 Oct 2026

Osteopathic treatment safely improves head shape in infants with plagiocephaly

Physicians used osteopathic manipulative treatment to effectively improve the head shape of babies who developed a flattened spot on the back or side of their head, a condition called positional plagiocephaly (PP), according to research presented during the American Academy of Pediatrics 2026 National Conference & Exhibition in San Diego Oct. 2-6.

5 Oct 2026

Dana-Farber research reveals possible new target for treatment of sickle cell and beta thalassemia

That pathway involves BACH2 and NRF2 and was discovered using a large genome-wide association study that enabled an analysis of genes related to fetal hemoglobin from a wide range of ancestries, including European, African, and Asian ancestries.

5 Oct 2026

Gut mRNA tech supercharges vaccine and GLP-1 delivery

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go.

5 Oct 2026

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Tirzepatide cuts body fat while preserving skeletal muscle in real-world study

2 Oct 2026

Online approach helped patients manage anxiety after chest pain

The PACER study reveals that peer-supported CBT significantly lowers anxiety in low-risk chest pain patients, enhancing mental health in emergency settings.

2 Oct 2026

Ultrasensitive AMH testing offers new insights into midlife ovarian reserve

In women's lifelong health management, the years from 35 to 55 form a critical transition period. During this period, many women face a triple challenge: declining fertility, bothersome perimenopausal symptoms, and delayed or delays in recognizing or confirming menopause.

1 Oct 2026

Lab-grown human pituitary cells work and survive after transplantation into a primate

Researchers in Japan have transplanted pituitary tissue grown from human stem cells into a primate whose pituitary gland had been surgically removed, successfully restoring critical hormone signals.

1 Oct 2026

Phage proteases activate bacterial immune response to viral infection

In the fight to find better treatments for bacterial infections, one rapidly evolving therapy is a group of viruses called bacteriophages (phages). Phages can attack and kill dangerous bacteria while leaving human cells unharmed and bypassing antibiotic resistance.

1 Oct 2026

Study links immune status to herpesvirus retinitis progression

The clinical progression and outcomes of two major herpesvirus retinitis forms are associated with patients' immune status, reveal Institute of Science Tokyo scientists.

1 Oct 2026

Kingston University joins major London partnership for health and social care research

Kingston University, London has joined a new London-wide partnership to deliver health and social care transformation through research.

1 Oct 2026

Trevogrumab cuts semaglutide-induced lean mass loss by half, study shows

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and in press with The Lancet shows that using the trevogrumab to inhibit myostatin, a protein that negatively regulates muscle mass, can reduce lean mass loss during treatment with semaglutide by 50% compared with semaglutide and placebo.

1 Oct 2026

Policy review demands better quality of life data in cancer clinical trials

A new policy review from Common Sense Oncology (CSO) and the European Organisation for Research and Treatment of Cancer (EORTC) calls for quality of life data to play a more central role in clinical trials evaluating adjuvant cancer treatments.

1 Oct 2026

Previous
1
...
10
11
12
13
14
15
16
...
2953
Next

Therapy News and Research

Cannabis products associated with sustained improvements in patients with inflammatory arthritis

Terumo Blood and Cell Technologies partners with TrAMPoline Pharma to automate TIL therapy manufacturing for solid tumors

Phase III trial tests MRD-guided treatment for patients with ER-positive/HER2-negative breast cancer

New BCR analysis method tracks immune recovery after stem cell transplantation

New model predicts growth hormone therapy response in children with short stature

New workflow rapidly identifies deadly fungal bloodstream infections

Enlicitide offers oral treatment option for patients avoiding cholesterol injections

Tailored treatments allow less invasive surgery for breast cancer patients

Osteopathic treatment safely improves head shape in infants with plagiocephaly

Dana-Farber research reveals possible new target for treatment of sickle cell and beta thalassemia

Gut mRNA tech supercharges vaccine and GLP-1 delivery

Tirzepatide cuts fat mass by 35% while preserving skeletal muscle

Online approach helped patients manage anxiety after chest pain

Ultrasensitive AMH testing offers new insights into midlife ovarian reserve

Lab-grown human pituitary cells work and survive after transplantation into a primate

Phage proteases activate bacterial immune response to viral infection

Study links immune status to herpesvirus retinitis progression

Kingston University joins major London partnership for health and social care research

Trevogrumab cuts semaglutide-induced lean mass loss by half, study shows

Policy review demands better quality of life data in cancer clinical trials

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News